Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00468299 · ClinicalTrials.gov registry record · NA
MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure
A NA study, sponsored by Boston University.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00468299 is a NA study that was terminated before completion, run by Boston University. The registered enrollment target is 16 participants.
The verdict
NCT00468299, a NA study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two combinations of drugs (mifepristone and misoprostol versus placebo and misoprostol) used for medical treatment for early pregnancy failure. We will compare the two combinations of medications to see which combination makes miscarriage happen faster. We hypothesize that there will be no difference in time to complete miscarriage between the two groups.
Interventions
- DRUG Mifepristone and misoprostol
- DRUG Misoprostol and placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00468299
The ClinicalTrials.gov registry entry for NCT00468299 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mifepristone and misoprostol is the first listed.
NCT00468299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00468299 about?
NCT00468299 is a clinical study titled "MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure". The purpose of this study is to compare two combinations of drugs (mifepristone and misoprostol versus placebo and misoprostol) used for medical treatment for early pregnancy failure. We will compare the two combinations of medications to see which combination makes miscarriage happen faster. We hyp...
What is the current status of trial NCT00468299?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2007-04. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00468299?
The interventions under investigation include: Mifepristone and misoprostol (DRUG), Misoprostol and placebo (DRUG).
Who is sponsoring clinical trial NCT00468299?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.